Abstract

Lightweight deep convolutional neural networks (CNNs) present a good solution to achieve fast and accurate image-guided diagnostic procedures of COVID-19 patients. Recently, advantages of portable Ultrasound (US) imaging such as simplicity and safe procedures have attracted many radiologists for scanning suspected COVID-19 cases. In this paper, a new framework of lightweight deep learning classifiers, namely COVID-LWNet is proposed to identify COVID-19 and pneumonia abnormalities in US images. Compared to traditional deep learning models, lightweight CNNs showed significant performance of real-time vision applications by using mobile devices with limited hardware resources. Four main lightweight deep learning models, namely MobileNets, ShuffleNets, MENet and MnasNet have been proposed to identify the health status of lungs using US images. Public image dataset (POCUS) was used to validate our proposed COVID-LWNet framework successfully. Three classes of infectious COVID-19, bacterial pneumonia, and the healthy lung were investigated in this study. The results showed that the performance of our proposed MnasNet classifier achieved the best accuracy score and shortest training time of 99.0% and 647.0 s, respectively. This paper demonstrates the feasibility of using our proposed COVID-LWNet framework as a new mobile-based radiological tool for clinical diagnosis of COVID-19 and other lung diseases.

Highlights

  • Coronavirus Disease 2019 (COVID-19) was identified in Wuhan City, China

  • Small subpleural consolidation and pleural irregularities can be shown for the positive case of COVID-19, while dynamic air bronchograms surrounded by alveolar consolidation are the main symptoms of bacterial pneumonia disease

  • The proposed lightweight deep learning classifiers are categorized into four main models, which are MobileNets, ShuffleNets, MENet and MnasNet

Read more

Summary

Introduction

COVID-19 pandemic becomes a global health issue, which leads to severe acute respiratory illness. It has affected more than hundred and fourteen million people around the world, and the death cases of more than two and half millions in 187 countries, regions, or territories [1]. The World Health Organization (WHO) has reported that the total number of confirmed infectious cases worldwide is 105,394,301 and the number of deaths is 2,302,302 [2,3]. The most common clinical symptoms in patients with COVID-19 are fever and cough, shortness of breath and other breathing difficulties [4]. Patients have a fever in the first place with or without respiratory symptoms

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call